8-KLeadership ChangesRegulation FDExhibits & Filings

Zoetis Inc. 8-K Report, Executive Changes (Oct 28, 2025)

Filed October 28, 2025For Securities:ZTS

Summary

Zoetis Inc. (ZTS) announced a strategic addition to its Board of Directors, appointing Stephanie Tilenius as a new member, effective December 1, 2025. This appointment will increase the Board's size from twelve to thirteen directors. Ms. Tilenius brings significant experience, which is expected to contribute to the company's strategic direction and governance. The company has also confirmed that Ms. Tilenius's appointment is not contingent on any third-party arrangements and that there have been no reportable related-party transactions. She will be compensated according to the company's standard non-employee director compensation program, and Zoetis will enter into its standard indemnification agreement with her. The announcement was made via a press release on October 28, 2025.

Key Highlights

  • 1Stephanie Tilenius appointed to Zoetis Board of Directors, effective December 1, 2025.
  • 2Board size will increase from 12 to 13 members.
  • 3Appointment is independent of third-party arrangements.
  • 4No reportable related-party transactions involving Ms. Tilenius.
  • 5Ms. Tilenius will participate in the standard non-employee director compensation program.
  • 6Zoetis will enter into a standard indemnification agreement with Ms. Tilenius.

Frequently Asked Questions

While the 8-K filing does not detail Ms. Tilenius's specific background or experience, her appointment to the Board suggests she possesses valuable expertise that the company believes will benefit Zoetis's strategic oversight and governance.

The Board size is increasing from twelve to thirteen members to accommodate the appointment of Stephanie Tilenius, reflecting the company's decision to expand its directorial capacity.

No, Ms. Tilenius will be eligible for participation in Zoetis's standard non-employee director compensation program, as outlined in the company's proxy statement.

The filing explicitly states that Ms. Tilenius was not appointed pursuant to any arrangements with third parties, and there have been no reportable related-party transactions between Ms. Tilenius and Zoetis since the beginning of the last fiscal year.